Inventaire - your friends and communities are your best library - Inventaire

Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis

published in: Atherosclerosis

date of publication: 2015-09

language: English

main subject: atherosclerosis

Cites articles 94

Date

Title

Authors

2015-04

Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism
2015-06-01

The remnants of residual risk

Roger S. Blumenthal
2015-06-03

Proof That Lower Is Better--LDL Cholesterol and IMPROVE-IT

John Keaney
2015-06-03

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Eugene Braunwald, Robert P Giugliano, Robert Califf, Antonio Zingarelli, Christopher P Cannon, Michael A Blazing, Witold Rużyłło, J Wouter Jukema, Stephen D Wiviott, Erin A Bohula, Amy McCagg, Pierre Theroux, Craig J Reist, Andrew M Tershakovec, Thomas A Musliner, IMPROVE-IT Investigators
2015-03-15

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events

Robert P Giugliano, Dirk J Blom, Robert Scott, Christie M. Ballantyne, Frederick J Raal
2015-03-15

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events

John J. P. Kastelein, Michel Krempf, Frederick J Raal, Erik Stroes
2015-04-20

Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic Syndrome.

Christie M. Ballantyne
2015-01-08

Triglyceride-rich lipoproteins and coronary artery disease risk: new insights from human genetics
2015-03-19

Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis
2015-05-27

Eicosapentaenoic Acid Prevents Saturated Fatty Acid-Induced Vascular Endothelial Dysfunction: Involvement of Long-Chain Acyl-CoA Synthetase.

Takayuki Ishida
2014-02-01

Eicosapentaenoic Acid combined with optimal statin therapy improves endothelial dysfunction in patients with coronary artery disease

Yoshiaki Maruyama
2014-03-05

Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma
2014-10-18

Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia
2014-10-22

Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanism
2014-08-19

Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: a randomized, controlled study
2014-07-01

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Neil J Stone, Daniel Levy, Alice H. Lichtenstein, Donald Lloyd-Jones
2014-12-16

Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease

Sekar Kathiresan
2014-05-09

Eicosapentaenoic acid induces neovasculogenesis in human endothelial progenitor cells by modulating c-kit protein and PI3-K/Akt/eNOS signaling pathways

Shao-Chih Chiu, En-Pei Isabel Chiang
2014-08-01

Triglycerides and cardiovascular disease

Børge G. Nordestgaard
2014-06-18

Loss-of-function mutations in APOC3, triglycerides, and coronary disease

Goo Jun, Themistocles L Assimes, Thomas Meitinger, José María Ordovás, Alistair Scott Hall, Nathan O Stitziel, He Zhang, George Hindy, Anuj Goel, Martin Farrall, Stefano Duga, Rosanna Asselta, Oliviero Olivieri, Nicola Martinelli, Lisa W. Martin, Colin Palmer, Inke R. König, Juliane Kruppa, Omri Gottesman, Hugh Christian Watkins, Marju Orho-Melander, Ruth J. Loos, Jeanette Erdmann, Panos Deloukas, L. Adrienne Cupples, Kristian Hveem, Kari E North, Nora Franceschini, Olle Melander, James G. Wilson, Caroline S Fox, Christopher J O'Donnell, Deborah A Nickerson, Christie M. Ballantyne, Deborah N Farlow, Leslie A. Lange, Kathleen Stirrups, Eric Boerwinkle, Diego Ardissino, Elizabeth K Speliotes, Gina M Peloso, Wolf Lieb, Gonçalo Abecasis, Cristen J. Willer, Russell P Tracy, Nicholas J. Wareham, Bruce M. Psaty, Nilesh Samani, David Altshuler, Gail P. Jarvik, David R Crosslin, Raimund Erbel, Paul L Auer, Stephen S Rich, Oddgeir L Holmen, Erwin P Bottinger, Stavroula Kanoni, Jacy Crosby, Majid Nikpay, Stefan W. Escher, Jan-Håkan Jansson, Ruth McPherson, Charles Kooperberg, Franziska Degenhardt
2014-06-18

Loss-of-function mutations in APOC3 and risk of ischemic vascular disease

Børge G. Nordestgaard, Anne Tybjærg-Hansen, Ruth Frikke-Schmidt, Anders Berg Jørgensen
2014-12-29

Triglycerides on the rise: should we swap seats on the seesaw?

Peter Libby
2014-12-30

Ezetimibe: rescued by randomization (clinical and mendelian)
2014-01-24

Residual macrovascular risk in 2013: what have we learned?

Jean-Charles Fruchart, Jacques Genest jr., Evgeny Shlyakhto, Michel Krempf, Paul Zimmet, Philip J. Barter, Eleuterio Ferrannini, Jean Davignon, Yuji Matsuzawa, Hisao Ogawa, Peter Paul Toth
2014-06-10

Eicosapentaenoic acid protects against palmitic acid-induced endothelial dysfunction via activation of the AMPK/eNOS pathway
2014-08-15

Impact of eicosapentaenoic acid treatment on the fibrous cap thickness in patients with coronary atherosclerotic plaque: an optical coherence tomography study

Yasushi Ino, Takashi Akasaka, Takashi Kubo, Takashi Yamano, Yasutsugu Shiono
2013-02-01

Icosapent ethyl, a pure ethyl ester of eicosapentaenoic acid: effects on circulating markers of inflammation from the MARINE and ANCHOR studies

Christie M. Ballantyne
2013-11-14

Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases

Joan Clària, Charles N Serhan
2013-08-21

Monocytes in coronary artery disease and atherosclerosis: where are we now?

Gregory Lip, Eduard Shantsila, Andrew Devitt, Helen Griffiths, Angie Ghattas
2013-09-22

How do statins work?: changing paradigms with implications for statin allocation

Michael J Blaha
2013-08-28

Ratio of eicosapentaenoic acid to arachidonic acid is a critical risk factor for acute coronary syndrome in middle-aged older patients as well as younger adult patients
2013-08-01

Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on plasma and red blood cell fatty acids in patients with very high triglyceride levels (results from the MARINE study).

Article - wd:Q26801002

Welcome to Inventaire

the library of your friends and communities

you are offline